KH

Kevin Hammon

Vice President | EQT Life Sciences | Venture Capital

Amsterdam, North Holland

Invests in

Stages:

  • Min Investment:

    $11,000,000.00
  • Max Investment:

    $65,000,000.00
  • Target Investment:

    $25,000,000.00

Work Experience

  • Vice President

    2024

    EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies. With a track record going back 30 years, EQT Life Sciences has raised more than €3 billion, and invested in over 150 private companies.

  • Investment Associate

    2022 - 2024

2022 - 2022

  • Life Sciences Securities Research

    2022 - 2022

  • Sr Research Associate, Clinical Pharmacology (DMPK, PKPD, Pharmacometrics)

    2020 - 2020

  • Research Associate II, Clinical Pharmacology (DMPK, PKPD, Pharmacometrics)

    2018 - 2020

  • Research Associate I, Clinical Pharmacology (DMPK, PKPD, Pharmacometrics)

    2016 - 2018

2015 - 2016

  • Associate, Clinical Pharmacology Modeling and Simulation

    2015 - 2016

  • Quality Analyst I

    2014 - 2015